Point72 Hong Kong Ltd - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,000
-50.0%
1,741
-23.5%
0.00%
Q1 2022$6,000
-82.9%
2,276
-69.9%
0.00%
-100.0%
Q4 2021$35,000
-62.8%
7,564
-31.4%
0.00%
-66.7%
Q3 2021$94,000
+235.7%
11,023
+557.3%
0.00%
+200.0%
Q2 2021$28,000
-33.3%
1,677
-12.2%
0.00%0.0%
Q1 2021$42,0001,9090.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$11,748,0004.96%
MPM BioImpact LLC 3,370,982$9,776,0002.72%
TANG CAPITAL MANAGEMENT LLC 3,641,606$10,561,0001.60%
Newtyn Management, LLC 692,799$2,009,0000.38%
K2 PRINCIPAL FUND, L.P. 1,078,070$3,126,0000.34%
HARBOR CAPITAL ADVISORS, INC. 64,341$187,0000.14%
Redmile Group, LLC 1,094,645$3,174,0000.12%
Artal Group S.A. 750,000$2,175,0000.12%
Oasis Management Co Ltd. 200,000$580,0000.10%
X-Square Capital, LLC 31,919$93,0000.06%
View complete list of TCR2 THERAPEUTICS INC shareholders